| Title |
The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study
|
|---|---|
| Published in |
Cancer Management and Research, August 2024
|
| DOI | 10.2147/cmar.s472196 |
| Pubmed ID | |
| Authors |
Xiaobing Li, De Wu, Jing Tang, Yuebing Wu |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2024.
All research outputs
#21,557,464
of 26,465,533 outputs
Outputs from Cancer Management and Research
#1,154
of 2,111 outputs
Outputs of similar age
#112,082
of 176,217 outputs
Outputs of similar age from Cancer Management and Research
#1
of 5 outputs
Altmetric has tracked 26,465,533 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,111 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,217 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them